HealthEquity, Inc. (NASDAQ:HQY – Free Report) – Analysts at Barrington Research lifted their Q3 2024 earnings per share (EPS) estimates for HealthEquity in a note issued to investors on Wednesday, September 20th. Barrington Research analyst A. Paris now expects that the company will earn $0.32 per share for the quarter, up from their previous estimate of $0.29. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. The consensus estimate for HealthEquity’s current full-year earnings is $1.35 per share. Barrington Research also issued estimates for HealthEquity’s FY2024 earnings at $1.32 EPS.
Several other research firms have also recently weighed in on HQY. Robert W. Baird raised HealthEquity from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $79.00 to $87.00 in a research report on Thursday. StockNews.com began coverage on HealthEquity in a research report on Thursday, August 17th. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $71.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, September 7th. Finally, Royal Bank of Canada raised their target price on HealthEquity from $75.00 to $77.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 6th. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $84.00.
HealthEquity Stock Up 0.6 %
HQY opened at $72.65 on Monday. HealthEquity has a 1-year low of $48.86 and a 1-year high of $79.20. The company has a current ratio of 4.09, a quick ratio of 4.09 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $6.22 billion, a price-to-earnings ratio of 484.33, a P/E/G ratio of 2.24 and a beta of 0.79. The business has a 50 day moving average of $67.42 and a 200-day moving average of $61.75.
Insider Buying and Selling at HealthEquity
In other news, insider Tyson D. Murdock sold 2,844 shares of the firm’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $71.35, for a total value of $202,919.40. Following the completion of the sale, the insider now directly owns 70,389 shares in the company, valued at $5,022,255.15. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 2.70% of the company’s stock.
Institutional Trading of HealthEquity
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Portside Wealth Group LLC acquired a new stake in shares of HealthEquity in the second quarter valued at $5,162,000. Teachers Retirement System of The State of Kentucky increased its position in HealthEquity by 9.1% in the second quarter. Teachers Retirement System of The State of Kentucky now owns 38,590 shares of the company’s stock worth $2,436,000 after purchasing an additional 3,227 shares during the period. Orion Portfolio Solutions LLC acquired a new stake in HealthEquity in the second quarter worth about $209,000. Coppell Advisory Solutions LLC acquired a new stake in HealthEquity in the second quarter worth about $48,000. Finally, Wells Fargo & Company MN increased its position in HealthEquity by 22.6% in the second quarter. Wells Fargo & Company MN now owns 81,203 shares of the company’s stock worth $5,127,000 after purchasing an additional 14,964 shares during the period. 98.46% of the stock is currently owned by institutional investors and hedge funds.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Reasons This Sleeping Giant Is About To Wake Up
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- MarketBeat Week in Review – 9/18 – 9/22
- What Does Downgrade Mean in Investing?
- 52-week Low Names To Tip The Upside Scale In Your Favor
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
